Ligand Pharmaceuticals logo

Ligand Pharmaceuticals

LGND | NASDAQ
Chart Builder DCF Calculator
$293.04
+$2.97 (+1.02%)
Sep 22, 2026, 12:07 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
174.93M 72.31M 22.95M 45.01M 19.52M 47.62M
Short-Term Investments
558.59M 183.86M 147.36M 166.86M 321.59M 363.57M
Long-Term Investments
183.58M 10.91M 111.61M 3M n/a n/a
Other Long-Term Assets
1.79M 202.53M 9.92M 1.74M 272.03M 4.27M
Receivables
61.05M 42.45M 39.31M 35.04M 91.65M 59.06M
Inventory
9.13M 14.11M 23.97M 13.29M 27.33M 26.49M
Other Current Assets
28.58M 16.9M 2.66M 2.27M 4.67M 3.82M
Total Current Assets
832.27M 331.56M 237.43M 263.6M 464.75M 500.56M
Property-Plant & Equipment
10.79M 24.81M 25.06M 27.49M 32.6M 37.17M
Goodwill & Intangibles
523.86M 371.9M 402.98M 458.31M 492.47M 795.97M
Total Long-Term Assets
728.37M 610.22M 549.79M 499.07M 832.84M 861.73M
Total Assets
1.56B 941.77M 787.22M 762.67M 1.3B 1.36B
Account Payables
3.24M 5.23M 2.43M 5.31M 8.4M 3.78M
Deferred Revenue
621K 1.9M 1.84M 976K 654K 29.44M
Short-Term Debt
n/a n/a n/a 76.7M n/a n/a
Other Current Liabilities
6.81M -3.2M 4.94M 6.26M 22.57M 49.38M
Total Current Liabilities
37.45M 37.11M 16.78M 98.81M 41.67M 100.11M
Long-Term Debt
446.19M n/a n/a n/a 320.72M 442.29M
Other Long-Term Liabilities
2.97M 35.88M 17M 25.38M 80.94M 40.12M
Total Long-Term Liabilities
505.98M 74.22M 69.52M 66.37M 434.77M 552.65M
Total Liabilities
543.43M 111.34M 86.3M 165.18M 476.43M 652.76M
Total Debt
451.49M 7.11M 6.17M 87.75M 324.39M 456.41M
Book Value
1.02B 830.44M 700.91M 597.49M 821.16M 709.53M
Book Value Per Share
50.12 45.40 39.47 35.42 47.61 43.84
Common Stock
20K 20K 18K 17K 17K 16K
Retained Earnings
608.09M 498.98M 503.02M 450.86M 449.09M 391.95M
Comprehensive Income
8.46M -5.94M -817K -984K -917K -801K
Shareholders Equity
1.02B 830.44M 700.91M 597.49M 821.16M 709.53M
Total Investments
742.18M 194.77M 258.97M 169.86M 321.59M 363.57M

© 2026 bestshares.com. All rights reserved.